Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial

Despite the use of intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy (CCRT), the treatment of locoregionally advanced nasopharyngeal carcinoma (LA-NPC) is not satisfactory. EGFR and VEGFR are highly expressed in 60–80% of patients with LA-NPC and this is associated with a poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kequan, Xu, Guoding, Liang, Yong, Liang, Ping, Gao, Weiwei, Li, Zhou, Liang, Weichao, Tao, Zheng, Chen, Jiaxin, Hu, Xiaohua, Xu, Yaocan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435931/
https://www.ncbi.nlm.nih.gov/pubmed/37600344
http://dx.doi.org/10.3892/ol.2023.13978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435931/
https://www.ncbi.nlm.nih.gov/pubmed/37600344
http://dx.doi.org/10.3892/ol.2023.13978

Ejemplares similares